Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients
Conclusions: The pretreatment SII and EBV DNA levels are promising factors for predicting survival in locally advanced NPC patients. The combination of them, which was superior to either score alone, was a complement to the conventional TNM staging system.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Ying Xiong, Liang-Liang Shi, Li-Sheng Zhu, Qian Ding, Li Ba, Gang Peng Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Nasopharyngeal Cancer | Study | Training | Universities & Medical Training